These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27058904)

  • 1. Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis.
    Volpato M; Perry SL; Marston G; Ingram N; Cockbain AJ; Burghel H; Mann J; Lowes D; Wilson E; Droop A; Randerson-Moor J; Coletta PL; Hull MA
    Oncotarget; 2016 May; 7(19):28139-50. PubMed ID: 27058904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility.
    Hawcroft G; Volpato M; Marston G; Ingram N; Perry SL; Cockbain AJ; Race AD; Munarini A; Belluzzi A; Loadman PM; Coletta PL; Hull MA
    Br J Pharmacol; 2012 Jul; 166(5):1724-37. PubMed ID: 22300262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol.
    Hull MA; Ow PL; Ruddock S; Brend T; Smith AF; Marshall H; Song M; Chan AT; Garrett WS; Yilmaz O; Drew DA; Collinson F; Cockbain AJ; Jones R; Loadman PM; Hall PS; Moriarty C; Cairns DA; Toogood GJ
    BMJ Open; 2023 Nov; 13(11):e077427. PubMed ID: 38030258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
    Cockbain AJ; Volpato M; Race AD; Munarini A; Fazio C; Belluzzi A; Loadman PM; Toogood GJ; Hull MA
    Gut; 2014 Nov; 63(11):1760-8. PubMed ID: 24470281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
    Volpato M; Ingram N; Perry SL; Spencer J; Race AD; Marshall C; Hutchinson JM; Nicolaou A; Loadman PM; Coletta PL; Hull MA
    Cancer Chemother Pharmacol; 2021 Feb; 87(2):173-184. PubMed ID: 33040178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of red blood cell eicosapentaenoic acid (EPA) levels in a randomised trial of EPA in patients with colorectal cancer liver metastases.
    Watson H; Cockbain AJ; Spencer J; Race A; Volpato M; Loadman PM; Toogood GJ; Hull MA
    Prostaglandins Leukot Essent Fatty Acids; 2016 Dec; 115():60-66. PubMed ID: 27914515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative elevation in the plasma CCL2 level is a predictive biomarker of colorectal cancer recurrence.
    Fukunaga M; Mimori K; Masuda T; Hu Q; Yamada K; Mori M
    Surg Today; 2021 Oct; 51(10):1671-1681. PubMed ID: 33797637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche.
    Chen C; Yao X; Xu Y; Zhang Q; Wang H; Zhao L; Wen G; Liu Y; Jing L; Sun X
    J Ethnopharmacol; 2019 Jun; 238():111878. PubMed ID: 30986521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota.
    Piazzi G; D'Argenio G; Prossomariti A; Lembo V; Mazzone G; Candela M; Biagi E; Brigidi P; Vitaglione P; Fogliano V; D'Angelo L; Fazio C; Munarini A; Belluzzi A; Ceccarelli C; Chieco P; Balbi T; Loadman PM; Hull MA; Romano M; Bazzoli F; Ricciardiello L
    Int J Cancer; 2014 Nov; 135(9):2004-13. PubMed ID: 24676631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum chemokine (C-C motif) ligand 2 levels and prognosis in colorectal cancer.
    Szczepanik AM; Siedlar M; Szura M; Kibil W; Brzuszkiewicz K; Brandt P; Kulig J
    Pol Arch Med Wewn; 2015; 125(6):443-51. PubMed ID: 26020569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial.
    Read JA; Beale PJ; Volker DH; Smith N; Childs A; Clarke SJ
    Support Care Cancer; 2007 Mar; 15(3):301-7. PubMed ID: 17021855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma and erythrocyte omega-6 and omega-3 fatty acids in response to intravenous supply of omega-3 fatty acids in patients with hepatic colorectal metastases.
    Al-Taan O; Stephenson JA; Spencer L; Pollard C; West AL; Calder PC; Metcalfe M; Dennison AR
    Lipids Health Dis; 2013 May; 12():64. PubMed ID: 23648075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated AA/EPA Ratio Represents an Inflammatory Biomarker in Tumor Tissue of Metastatic Colorectal Cancer Patients.
    Tutino V; De Nunzio V; Caruso MG; Veronese N; Lorusso D; Di Masi M; Benedetto ML; Notarnicola M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells.
    Hawcroft G; Loadman PM; Belluzzi A; Hull MA
    Neoplasia; 2010 Aug; 12(8):618-27. PubMed ID: 20689756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in Apc(Min/+) mice.
    Fini L; Piazzi G; Ceccarelli C; Daoud Y; Belluzzi A; Munarini A; Graziani G; Fogliano V; Selgrad M; Garcia M; Gasbarrini A; Genta RM; Boland CR; Ricciardiello L
    Clin Cancer Res; 2010 Dec; 16(23):5703-11. PubMed ID: 21030497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Application of Eicosapentaenoic Acid Monoacylglyceride in the Management of Colorectal Cancer.
    Morin C; Rodríguez E; Blier PU; Fortin S
    Mar Drugs; 2017 Sep; 15(9):. PubMed ID: 28869531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eicosapentaenoic acid administration attenuates the pro-inflammatory properties of VLDL by decreasing its susceptibility to lipoprotein lipase in macrophages.
    Jinno Y; Nakakuki M; Kawano H; Notsu T; Mizuguchi K; Imada K
    Atherosclerosis; 2011 Dec; 219(2):566-72. PubMed ID: 22018640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acids ameliorate vascular inflammation: A rationale for their atheroprotective effects.
    Pisaniello AD; Psaltis PJ; King PM; Liu G; Gibson RA; Tan JT; Duong M; Nguyen T; Bursill CA; Worthley MI; Nicholls SJ; Di Bartolo BA
    Atherosclerosis; 2021 May; 324():27-37. PubMed ID: 33812168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.